Skip to main content
main-content

Devices and technology

Pregnancy

11-07-2018 | Pregnancy | News

Surprising CONCEPTT findings on insulin pumps versus injections in pregnant women

A prespecified analysis of the CONCEPTT trial shows that pregnant women with type 1 diabetes who were using pumps at baseline did not achieve as good glycemic control as those using multiple daily injections.

Source:

Diabetes Care 2018; doi:10.2337/dc18-1437

06-13-2018 | Neonatal diabetes | Review | Article

Congenital diabetes: Comprehensive genetic testing allows for improved diagnosis and treatment of diabetes and other associated features

Letourneau LR, Greeley SAW. Curr Diab Rep 2018; 18: 46. doi: 10.1007/s11892-018-1016-2

05-24-2018 | Devices and technology | Review | Article

Telemedicine in complex diabetes management

McDonnell ME. Curr Diab Rep 2018; 18: 42. doi: 10.1007/s11892-018-1015-3

03-27-2018 | Pregnancy | News

Closed-loop insulin delivery shows promise in pregnancy

A small study suggests that closed-loop insulin delivery can produce equivalent glycemic control to that of sensor-augmented pump delivery, but with less hypoglycemia, during 1 month of use by pregnant women with type 1 diabetes.

Source:

Diabetes Care 2018; Advance online publication

02-06-2018 | Pregnancy | Review | Article

Caring for pregnant women whose diabetes antedates pregnancy: Is there room for improvement?

Sacks DA, Feig DS. Diabetologia 2018; Advance online publication. doi: 10.1007/s00125-018-4565-7

12-19-2017 | Pregnancy | Case report | Article

Successful glycemic control using a flash glucose monitoring system for a pregnant woman with diabetes: A case report

Kishimoto M, Tamada S, Oshiba Y. J Diabetes Metab Disord 2017; 16: 44. doi: 10.1186/s40200-017-0327-1

11-07-2017 | Pregnancy | News

October Cochrane review round-up

The two diabetes-related Cochrane reviews published in October focused on diabetes during pregnancy; the first covered different methods of glucose monitoring, while the second compared oral antidiabetic agents with insulin, with both concluding that better quality research is needed to draw firm conclusions.

Source:

Cochrane Database Syst Rev 2017; 10: CD011069, CD007724

09-20-2017 | Pregnancy | EASD 2017 | Video

Expert commentary: The CONCEPTT trial

Harold de Valk discusses the importance of the ​​​​​​​CONCEPTT trial results for pregnant women with type 1 diabetes (3:08).
Read the accompanying news story

09-15-2017 | Continuous glucose monitoring | EASD 2017 | News

CGM use during pregnancy improves maternal glycemic control, neonatal outcomes

The CONCEPTT trial results suggest that the use of continuous glucose monitoring by pregnant women with type 1 diabetes improves glycemic control and neonatal outcomes relative to standard glucose monitoring.

Source:

Lancet 2017; Advance online publication

image credits